Shuttle Pharmaceuticals Holdings, Inc. earnings releases SHPH

Annual Quarterly

Shuttle Pharmaceuticals Holdings, Inc. last reported quarterly results on Feb 17, 2026, for Q4 FY2025 (the quarter ended Dec 31, 2025): diluted EPS of -$0.95. It usually reports 44–57 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 44–57 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Feb 17, 2026 48 days after quarter end	Q4 FY2025 ended Dec 31, 2025	—	-3 -63.6%	-0.95 +88.2%
Feb 26, 2025 57 days after quarter end	Q4 FY2024 ended Dec 31, 2024	—	-2 +2.6%	-8.04
Nov 13, 2024 44 days after quarter end	Q3 FY2024 ended Sep 30, 2024	—	-4 -111.1%	-39.83 -4276.9%
May 14, 2024 44 days after quarter end	— ended Mar 31, 2024	—	—	—
Nov 14, 2023 45 days after quarter end	— ended Sep 30, 2023	—	—	—
Aug 15, 2023 46 days after quarter end	— ended Jun 30, 2023	—	—	—
May 26, 2023 56 days after quarter end	— ended Mar 31, 2023	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: SHPH (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Gaithersburg, MD
SEC filer status: , Emerging growth company
SEC CIK: 1757499
Former names: Shuttle Pharmaceuticals Holdings, Inc. (until Oct 22, 2026)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.